Heart failure (HF) is a condition with high mortality worldwide characterized by persistent progression. Myocardial hypertrophy is a dominant feature during the early stage of HF. The development of HF is a complex process related to a series of physiologic and molecular factors. Although the treatment of HF has been changed during the past century, the knowledge on its molecular mechanism is still very limited. The review herein tries to touch the molecular basis underlying HF and discusses the relevance between HF and other diseases such as thrombosis. Furthermore, we believe that the global alterations during progression of HF revealed by high content screening techniques may facilitate our understanding on HF, and thereby the developmen...
heart failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of p...
International audienceBackground Identifying the mechanistic pathways potentially associated with in...
Background Identifying the mechanistic pathways potentially associated with incident heart failure (...
Heart failure (HF) is the inability of the heart to cope with the metabolic demands of the periphery...
Heart failure (HF) is the end-stage of all heart disease and arguably constitutes the greatest unmet...
BACKGROUND: Identifying the mechanistic pathways potentially associated with incident heart failure ...
Background: Information on the pathophysiological differences between heart failure with reduced eje...
The progressive nature of heart failure (HF) is the predominant cause for the clinical course that t...
Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF can be cla...
BACKGROUND: Information on the pathophysiological differences between heart failure with reduced eje...
With 550 000 new cases diagnosed annually and $37 billion spent per year,1 heart failure (HF) with r...
Heart failure is a final common pathway in cardiovascular disease, as a result of sustained pressure...
Age-related diastolic dysfunction is a major factor in the epidemic of heart failure. In patients ho...
International audienceAims: Heart failure (HF) is frequently caused by an ischaemic event (e.g. myoc...
heart failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of p...
International audienceBackground Identifying the mechanistic pathways potentially associated with in...
Background Identifying the mechanistic pathways potentially associated with incident heart failure (...
Heart failure (HF) is the inability of the heart to cope with the metabolic demands of the periphery...
Heart failure (HF) is the end-stage of all heart disease and arguably constitutes the greatest unmet...
BACKGROUND: Identifying the mechanistic pathways potentially associated with incident heart failure ...
Background: Information on the pathophysiological differences between heart failure with reduced eje...
The progressive nature of heart failure (HF) is the predominant cause for the clinical course that t...
Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF can be cla...
BACKGROUND: Information on the pathophysiological differences between heart failure with reduced eje...
With 550 000 new cases diagnosed annually and $37 billion spent per year,1 heart failure (HF) with r...
Heart failure is a final common pathway in cardiovascular disease, as a result of sustained pressure...
Age-related diastolic dysfunction is a major factor in the epidemic of heart failure. In patients ho...
International audienceAims: Heart failure (HF) is frequently caused by an ischaemic event (e.g. myoc...
heart failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of p...
International audienceBackground Identifying the mechanistic pathways potentially associated with in...
Background Identifying the mechanistic pathways potentially associated with incident heart failure (...